cash runway – Talk Bio

Arcturus Prunes Early-Stage Pipeline to Focus on mRNA Therapies

4 weeks ago talkbio0Tagged Arcturus, biotech strategy, cash runway, Cystic Fibrosis, Kostaive, mRNA therapies, Ornithine carbamoyltransferase deficiency, pipeline reduction, vaccine programs

Arcturus Therapeutics; pipeline reduction; mRNA therapies; cystic fibrosis; ornithine transcarbamylase deficiency; Kostaive; vaccine programs; biotech strategy; cash runway

Lava cuts jobs by 30% after key drug discontinued

3 months ago talkbio0Tagged cash runway, Discontinuation (procedure), LAVA, LAVA-1266, mCRPC, restructuring, strategic alternatives

LAVA Therapeutics, restructuring, workforce reduction, LAVA-1207, discontinuation, mCRPC, LAVA-1266, strategic alternatives, cash runway

Bluebird’s Struggles with Sickle Cell Gene Therapy Launch Impact Financial Stability

10 months ago talkbio0Tagged Anemia, Sickle Cell, cash runway, Family Turdidae (organism), financial stability, gene therapy, Lyfgenia, rework

Bluebird Bio, sickle cell disease, gene therapy, Lyfgenia, loan rework, cash runway, financial stability